Clinical Trials List
Protocol NumberV-123
2021-07-15 - 2021-12-31
Phase I
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Po-Chang Lin Division of Infectious Disease
- 林伯昌 Division of Infectious Disease
- Wen-Yuan Lin Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
60 participants
